Arsenal Acquires Automation Solutions Provider Eckhart from LFM Capital

Arsenal Capital Partners (“Arsenal”), a private equity firm that specializes in investments in industrial growth and healthcare companies, today announced that it has acquired Eckhart Holdings, Inc. (“Eckhart”), a leading automation solutions provider from LFM Capital. Terms of the transaction were not disclosed.

Eckhart’s advanced engineering, design, simulation, and integration services, along with proprietary tooling and other automation and robotics systems, support customers at critical points in the automation value chain. Eckhart partners with blue-chip customers to design and implement automation solutions that solve complex problems and improve accuracy and efficiency in a number of attractive end markets, including ecommerce, engineered products, electric vehicles, transportation, and consumer products.

Andy Storm, CEO of Eckhart, commented, “We are excited to announce this strategic growth investment from Arsenal, which will enable us to take our business to new heights, scale our team, and better serve our customers. Arsenal’s extensive knowledge of the sector and track record of building high-growth, innovation-rich industrial technology businesses gave us confidence that they are the right partner.”

Aaron Wolfe, an Investment Partner of Arsenal, said, “We are thrilled to work closely with Eckhart’s senior leadership team to support a world-class automation platform in its next phase of growth. Eckhart’s solutions are critical to driving higher productivity, efficiency and precision, which is increasingly more valuable as customers compete on a global scale. Arsenal plans to invest a significant amount of incremental capital to accelerate growth, augment the solution set, and further penetrate attractive end markets.”

Daniel Burseth, Vice President of Eckhart, remarked, “The partnership with Arsenal comes at an opportune time as our customers invest at a record rate in automation for their operations. With Arsenal’s industrial track record and continued investment in expanding capabilities, Eckhart will become an even more important partner to a global customer base.”

Sal Gagliardo, an Operating Partner of Arsenal, added, “As systems increase in complexity, the design and integration of automation solutions becomes essential to efficient operations. We see significant opportunity ahead to leverage our collective industry expertise and deep financial resources to make Eckhart a clear innovation leader. As a firm, Arsenal will continue to invest in automation megatrends.

William Blair & Company L.L.C. served as financial advisor to Eckhart and LFM Capital on this transaction, and Bass, Berry & Sims PLC served as legal advisor to Eckhart and LFM. Harris Williams LLC served as financial advisor to Arsenal, and Kirkland & Ellis LLP served as legal advisor to Arsenal.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides our readership with breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The ArthroFree system is the first FDA-cleared wireless camera for arthroscopy and general endoscopy, both areas of minimally invasive surgery. The system is designed to help surgeons work with aximum dexterity and focus.
The project, which was led by the University of Southern California, included large increases in representation among men of African, Hispanic and Asian ancestries, that were contributed in part by an ongoing collaboration between the U.S. Department of Veterans Affairs and DOE reports Argonne.
This innovative software turns smartphones into medical-grade stethoscopes, allowing people to capture, analyze, and share critical heart health data with medical personnel from the comfort of any location notes Sparrow BioAcoustics.
"Taewoong Medical becoming an Olympus group company is also a major milestone in our global growth strategy," said Henry Shin, CEO of STARmed. "We look forward to our products being made available to more patients through Olympus' global distribution network."
The company reports they have successfully met the six-month primary endpoint for the first-ever female patient implanted with the UroActive™ System, the first smart automated artificial urinary sphincter (AUS) to treat SUI.

By using this website you agree to accept Medical Device News Magazine Privacy Policy